newsfilter
← Latest News
GlobeNewswire·

Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer

WATERTOWN, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. ("Acrivon" or "Acrivon Therapeutics") (NASDAQ:ACRV), a clinical stage biotechnology company discovering and developing